Tag archive for ‘Oramed Pharmaceuticals Inc’
Insulin diabetes- Health technology blood test 777001_640
Lily Bethlehem On Thursday, November 26th, 2020

Oramed Pharmaceuticals Advancing With an Oral Insulin

    Israel’s Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. It is moving forward with More...

Jewish Business News On Monday, November 30th, 2015

Oramed signs $50m oral insulin deal with China’s Hefei

Oramed Pharmaceuticals Inc., an Israeli clinical-stage company,  has signed definitive licensing and investment agreements valued at up to $50 million with Hefei Tianhui Incubator of Technologies Co.,  More...

Israeli Oramed to raise $50 million from two Chinese investors

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP),  has signed a non-binding Letter of Intent (LoI) for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science More...

Jewish Business News On Tuesday, June 16th, 2015

Israel’s Oramed Granted Patent in Russia for Oral Administration of GLP-1

– – Israeli startup Oramed Pharmaceuticals, a developer of oral drug delivery systems, has been granted by the Russian Federal Service for Intellectual Property a patent for its invention,  More...

Jewish Business News On Sunday, June 7th, 2015

Oramed to Raise $5.36 Million in Registered Direct Offering

– – Israeli startup Oramed Pharmaceuticals, a developer of oral drug delivery systems, announced that it entered into purchase agreements with several institutional investors for a registered More...

Wordpress site Developed by Fixing WordPress Problems